LD-2 disclosure · 4th Quarter - Report
CENCORA, INC.
via CENCORA, INC.
Client
- Name
- CENCORA, INC.
- Location
- District of Columbia · United States of America
Registrant
- Firm
- CENCORA, INC.
- Description
- Pharmaceutical Distributor
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
4 issuesMedicare/Medicaid
Medicare Part B Reimbursement. Average Sales Price (ASP). Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees The Equitable Community Access to Pharmacist Services Act (H.R. 1770/ S.2477). Inflation Reduction Act. Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Pharmacy and Medically Underserved Areas Enhancement Act (S.1491). Seniors Access to Critical Medicines Act (H.R. 5526/S.3458). Protecting Patient Access to Cancer and Complex Therapies Act (S. 2764). Reimbursement policies impacting drug shortages. Part B drug pricing changes. Enhanced Oncology Model (EOM).
LobbyistsVIVIENNE STAFFORD MITCHELL · SHELLY MUI-LIPNIK · DARRELL ROGERS
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
Pharmacy
Legislation to provide for coverage under Medicare program for pharmacist services. Pharmacy and Medically Underserved Area Enhancement Act (S.1491). House and Senate Agriculture, FDA, and related agency Appropriations bills. House and Senate Labor/HHS appropriations bills. Prescription drug importation. Issues and policies related to generic drug shortages. The Equitable Community Access to Pharmacist Services Act (H.R. 1770/S.2477).
LobbyistsVIVIENNE STAFFORD MITCHELL · SHELLY MUI-LIPNIK · DARRELL ROGERS
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
